Goldman Sachs Initiates Coverage of Four MDx Firms

In addition to initiating coverage of Cepheid, Gen-Probe, Myriad Genetics, and Qiagen, the investment bank also began coverage of Alere and Hologic.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.